Literature DB >> 29166300

Effect of Age on High T1 Signal Intensity of the Dentate Nucleus and Globus Pallidus in a Large Population Exposed to Gadodiamide.

Carlo Cosimo Quattrocchi, Yuri Errante, Carlo Augusto Mallio, Luca Marinelli, Gianguido LoVullo, Gabriele Giannotti, Sabino Walter Della Sala, Aart J van der Molen, Bruno Beomonte Zobel.   

Abstract

OBJECTIVE: The purpose of this study was to assess the effect of age and number of previous injections of gadodiamide on the signal intensity of unenhanced T1-weighted (T1w) images of the dentate nucleus and globus pallidus in a large population.
MATERIALS AND METHODS: A large, single-center retrospective population survey was designed and received institutional review board approval. Between January 2014 and December 2014, T1w signal intensity ratios were obtained from a large population of 2500 consecutive enhanced brain magnetic resonance imaging (MRI) scans. Of these, 1906 MRI scans of patients not previously exposed to any gadolinium (Gd)-based contrast agent were used as control group and were compared with 892 MRI scans of patients with documented prior exposure to intravenous gadodiamide. A quantitative study was conducted to assess the T1w signal intensity of dentate nucleus-to-pons (Dn/Po) and globus pallidus-to-thalamus (Gp/Th) ratios. Multiple regression analysis was used to test the effect of age, time delay, and number of previous Gd-based contrast agent injections as predictor variables of T1w signal intensity ratios.
RESULTS: In the Gd-exposed patients, multivariate regression analysis showed age (β = -0.285; P < 0.0001) and the number of previous injections of gadodiamide (β = 0.224; P < 0.0001) to be powerful predictors of Dn/Po ratio. Similarly, age (β = 0.269; P < 0.0001) and the number of previous injections of gadodiamide (β = 0.127; P < 0.0001) predicted Gp/Th ratio.
CONCLUSIONS: In this study, we confirm that the number of previous gadodiamide injections is a powerful predictor of the signal intensity increase of the Dn/Po and Gp/Th ratios on unenhanced T1w images and demonstrate that aging influences the T1 signal intensity of DN and GP in Gd-naïve and in Gd-exposed subjects.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29166300     DOI: 10.1097/RLI.0000000000000431

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  5 in total

Review 1.  Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.

Authors:  Carlo C Quattrocchi; Joana Ramalho; Aart J van der Molen; Àlex Rovira; Alexander Radbruch
Journal:  Eur Radiol       Date:  2018-11-09       Impact factor: 5.315

2.  Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents.

Authors:  Henning Richter; Patrick Bücker; Calvin Dunker; Uwe Karst; Patrick Robert Kircher
Journal:  PLoS One       Date:  2020-02-03       Impact factor: 3.240

3.  Assessment of gadolinium deposition in the brain tissue of pediatric and adult congenital heart disease patients after contrast enhanced cardiovascular magnetic resonance.

Authors:  Neil Zaki; David Parra; Quinn Wells; Joshua D Chew; Kristen George-Durrett; Sumit Pruthi; Jonathan Soslow
Journal:  J Cardiovasc Magn Reson       Date:  2020-12-03       Impact factor: 5.364

4.  Anterior pituitary gland T1 signal intensity is influenced by time delay after injection of gadodiamide.

Authors:  Carlo A Mallio; Laura Messina; Marco Parillo; Gianguido Lo Vullo; Bruno Beomonte Zobel; Paul M Parizel; Carlo C Quattrocchi
Journal:  Sci Rep       Date:  2020-09-11       Impact factor: 4.379

5.  Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging.

Authors:  Kathrin Barbara Krug; Christina Jane Burke; Kilian Weiss; Pascal A T Baltzer; Kerstin Rhiem; David Maintz; Marc Schlamann; Martin Hellmich
Journal:  Eur Radiol       Date:  2021-07-03       Impact factor: 5.315

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.